SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer

1. Van Hazel, G.A.
2. Heinemann, V.
3. Sharma, N.K.
4. Findlay, M.P.N.
5. Ricke, J.
6. Peeters, M.
7. Perez, D.
8. Robinson, B.A.
9. Strickland, A.H.
10. Ferguson, T.
11. Rodríguez, J.
12. Kröning, H.
13. Wolf, I.
14. Ganju, V.
15. Walpole, E.
16. Boucher, E.
17. Tichler, T.
18. Shacham-Shmueli, E.
19. Powell, A.
20. Eliadis, P.
21. Isaacs, R.
22. Price, D.
23. Moeslein, F.
24. Taieb, J.
25. Bower, G.
26. Gebski, V.
27. Van Buskirk, M.
28. Cade, D.N.
29. Thurston, K.
30. Gibbs, P.
31. Mostrar todos los/as autores/as +